• 1
    Ornatsky O,Baranov VI,Bandura DR,Tanner SD,Dick J. Multiple cellular antigen detection by ICP-MS. J Immunol Methods 2006; 308: 68–76.
  • 2
    Ornatsky OI Kinach R, Bandura DR, Lou X, Tanner SD, Baranov VI, Nitz M, Winnik MA. Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometry. J Anal At Spectrom 2008; 23: 463–469.
  • 3
    Bandura DR Baranov VI, Ornatsky OI, Antonov A, Kinach R, Lou X, Pavlov S, Vorobiev S, Dick JE, Tanner SD. Mass cytometry: Technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 2009; 81: 6813–6822.
  • 4
    Bendall SC Baranov VI, Ornatsky OI, Antonov A, Kinach R, Lou X, Pavlov S, Vorobiev S, Dick JE, Tanner SD. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011; 332: 687–696.
  • 5
    Qiu P Simonds EF, Bendall SC, Gibbs KD, Bruggner RV, Linderman MD, Sachs K, Nolan GP, Plevritis SK. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotech 2011; 29: 886–891.
  • 6
    Griffin J,Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185–1195.
  • 7
    Moore MA,Spitzer G,Williams N,Metcalf D,Buckley J. Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood 1974; 44: 1–18.
  • 8
    Raza A, Alvi S, Broady-Robinson L, Showel M, Cartlidge J, Mundle SD, Shetty VT, Borok RZ, Dar SE, Chopra HK, et al. Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. Exp Hematol 1997; 25: 530.
  • 9
    Pearce DJ Taussig D, Zibara K, Smith L-L, Ridler CM, Preudhomme C, Young BD, Rohatiner AZ, Lister TA, Bonnet D. AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML. Blood 2006; 107: 1166–1173.
  • 10
    Hahne F, LeMeur N, Brinkman RR, Ellis B, Haaland P, Sarkar D, Spidlen J, Strain E, Gentleman R. flowCore: A bioconductor package for high throughput flow cytometry. BMC Bioinformatics 2009; 10: 106.
  • 11
    Kotecha N,Krutzik PO,Irish JM. Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom Chapter 10, Unit10 17 ( 2010).
  • 12
    van Lochem EG, van der Velden VHJ, Wind HK, te Marvelde JG, Westerdaal NAC, van Dongen JJM Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shifts. Cytometry Part B: Clinical Cytometry 2004; 60B: 1–13.
  • 13
    Ornatsky OI Lou X, Nitz M, Schafer S, Sheldrick WS, Baranov VI, Bandura DR, Tanner SD. Study of cell antigens and intracellular DNA by identification of element-containing labels and metallointercalators using inductively coupled plasma mass spectrometry. Anal Chem 2008; 80: 2539–2547.
  • 14
    Rothaeusler K,Baumgarth N. Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry. Cytometry Part A( 2006); 69A; 249–259.
  • 15
    Ren S,Rollins BJ. Cyclin C/Cdk3 promotes Rb-dependent G0 Exit. Cell 2004; 117: 239–251.
  • 16
    Darzynkiewicz Z,Gong J,Juan G,Ardelt B,Traganos F. Cytometry of cyclin proteins. Cytometry 1996; 25: 1–13.
  • 17
    Juan G,Darzynkiewicz Z. Detection of mitotic cells. Curr Protoc Cytom 2004; Chapter 7, Unit 7 24.
  • 18
    Jacobberger JW,Sramkoski RM,Stefan T. Multiparameter cell cycle analysis. Methods in molecular biology 2011; 699: 229–249.
  • 19
    Goto H,Yasui Y,Nigg EA,Inagaki M. Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes to Cells 2002; 7: 11–17.
  • 20
    Hirata A, Inada K, Tsukamoto T, Sakai H, Mizoshita T, Yanai T, Masegi T, Goto H, Inagaki M, Tatematsu M. Characterization of a monoclonal antibody, HTA28, recognizing a histone H3 phosphorylation site as a useful marker of M-phase cells. J Histochem Cytochem 2004; 52: 1503–1509.
  • 21
    Darzynkiewicz Z,Juan G,Srour EF. Differential staining of DNA and RNA. Curr Protoc Cytom 2004; Chapter 7, Unit 7 3 .
  • 22
    Cheshier SH,Prohaska SS,Weissman IL. The effect of bleeding on hematopoietic stem cell cycling and self-renewal. Stem Cells Dev 2007; 16: 707–717.
  • 23
    Bryder D,Rossi DJ,Weissman IL. Hematopoietic stem cells: The paradigmatic tissue-specific stem cell. Am J Pathol 2006; 169: 338–346.
  • 24
    Darzynkiewicz Z,Crissman H,Jacobberger JW. Cytometry of the cell cycle: Cycling through history. Cytometry Part A 2004; 58A: 21–32.
  • 25
    Knudsen ES,Wang JY. Targeting the RB-pathway in cancer therapy. Clin Cancer Res 2010; 16: 1094–1099.
  • 26
    Dey-Guha I, Wolfer A, Yeh AC, G. Albeck J, Darp R, Leon E, Wulfkuhle J, Petricoin EF, Wittner BS, Ramaswamy S. Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci 2011; 108: 12845–12850.
  • 27
    Gong J,Ardelt B,Traganos F,Darzynkiewicz Z. Unscheduled expression of Cyclin B1 and Cyclin E in several leukemic and solid tumor cell lines. Cancer Res 1994; 54: 4285–4288.
  • 28
    Chao MP,Seita J,Weissman IL. Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb Symp Quant Biol 2008; 73: 439–449.
  • 29
    Cheshier SH,Morrison SJ,Liao X,Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1999; 96: 3120–3125.
  • 30
    Passegue E,Wagers AJ,Giuriato S,Anderson WC,Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005; 202: 1599–1611.
  • 31
    Head DR, Jacobberger JW, Mosse C, Jagasia M, Dupont W, Goodman S, Flye L, Shinar A, McClintock-Treep S, Stelzer G, Briggs R, Shults K. Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis. Bone Marrow Res 2011; 2011.
  • 32
    Preisler H. Prediction of response to chemotherapy in acute myelocytic leukemia. Blood 1980; 56: 361–367.